A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin

Nature
V K ChaudharyI Pastan

Abstract

Antibodies and growth factors have been chemically coupled to different toxins to produce cytotoxic molecules that selectively kill cells bearing appropriate antigens or receptors. Antibody-toxin conjugates (immunotoxins) produced using conventional chemical coupling techniques have several undesirable characteristics. The smallest binding unit of an antibody is an Fv fragment which consists of a light and heavy chain variable domain. Recently, active single chain Fv fragments of antibodies have been produced in Escherichia coli by attaching the light and heavy chain variable domains together with a peptide linker. Here we describe the construction and expression in E. coli of a single chain antibody toxin fusion protein, anti-Tac(Fv)-PE40, in which the variable regions of anti-Tac, a monoclonal antibody to the p55 subunit of the human interleukin-2 receptor, are joined in peptide linkage to PE40, a modified form of Pseudomonas exotoxin lacking its binding domain. Anti-Tac(Fv)-PE40 was very cytotoxic to two interleukin-2 receptor-bearing human cell lines but was not cytotoxic to receptor-negative cells.

References

Aug 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·J S HustonR Crea
Apr 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M C WillinghamI Pastan
Mar 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·H Lorberboum-GalskiI Pastan
Oct 21, 1988·Science·R E BirdM Whitlow
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·C B SiegallI Pastan
Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·V K ChaudharyI Pastan
Nov 20, 1987·Science·E S VitettaJ W Uhr
Dec 5, 1986·Cell·I PastanD J FitzGerald
May 5, 1986·Journal of Molecular Biology·F W Studier, B A Moffatt
Aug 1, 1981·Molecular Immunology·J A Berzofsky, A N Schechter

❮ Previous
Next ❯

Citations

Jan 1, 1996·Journal of Clinical Laboratory Analysis·J A Lust
Dec 18, 2001·International Journal of Cancer. Journal International Du Cancer·R NivY Reiter
Jan 1, 1992·Immunologic Research·H A VerheulE S Bos
Jan 22, 2010·Cancer Immunology, Immunotherapy : CII·Robert SarnovskyDavid J FitzGerald
Jul 31, 2013·Current Hematologic Malignancy Reports·Robert J Kreitman
Jun 16, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry
Sep 27, 1993·Journal of Immunological Methods·P J NichollsS M Andrew
May 11, 1995·Journal of Immunological Methods·U BrinkmannI Pastan
May 1, 1991·Enzyme and Microbial Technology·E Y ShamiM Zywulko
Sep 1, 1991·Molecular Immunology·H R HoogenboomJ C Raus
Feb 1, 1994·Molecular Immunology·E A Padlan
May 1, 1993·Trends in Pharmacological Sciences·T A Waldmann
Jul 1, 1990·Trends in Biotechnology·R A Spooner, J M Lord
Apr 1, 1991·Trends in Biotechnology·R E Bird, B W Walker
Apr 1, 1992·International Journal of Immunopharmacology·R J KreitmanI Pastan
Sep 1, 1990·Biochimie·G Lefranc, M P Lefranc
May 27, 1994·Biochimica Et Biophysica Acta·U Brinkmann, I Pastan
Apr 1, 1991·Current Opinion in Biotechnology·A Plückthun
Aug 1, 1992·Current Opinion in Biotechnology·L M Roberts, J M Lord
Oct 1, 1996·Molecular Medicine Today·U Brinkmann
Mar 24, 2005·Journal of Molecular Biology·Meital Gal-TanamyItai Benhar
Oct 31, 1991·Biochemical and Biophysical Research Communications·V K ChaudharyI Pastan
Feb 27, 2001·Journal of Immunological Methods·D M SegalL M Weiner
Mar 12, 2003·Journal of Molecular Biology·Martin KleinschmidtHauke Lilie
Jun 6, 2000·Advanced Drug Delivery Reviews·I Pastan, R J Kreitman
Dec 12, 1997·Biochimica Et Biophysica Acta·I Pastan

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
U BrinkmannI Pastan
Proceedings of the National Academy of Sciences of the United States of America
V K ChaudharyI Pastan
Proceedings of the National Academy of Sciences of the United States of America
J K BatraC R King
© 2022 Meta ULC. All rights reserved